IM-7 Identification of novel glioblastoma specific antigen using patient derived tumor cell for CAR-T cell therapy

Chimeric antigen receptor T (CAR-T) cell therapy is a newly developed antitumor immunotherapy presenting remarkable clinical response with leukemia, and is expected to be applied to other malignant solid tumors including glioblastoma (GBM). However, for development of CAR-T therapy against GBM, iden...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakagawa, Tomoyoshi, Kijima, Noriyuki, Hasegawa, Kana, Kuroda, Hideki, Hirayama, Ryuichi, Okita, Yoshiko, Kagawa, Naoki, Kanemura, Yonehiro, Hosen, Naoki, Kishima, Haruhiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Supplement Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8648191/
http://dx.doi.org/10.1093/noajnl/vdab159.029

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8648191/
http://dx.doi.org/10.1093/noajnl/vdab159.029

Ejemplares similares